Synapse Life Science Consortium

Synapse Life Science Consortium is a strategic broker dedicated to fostering collaborations within the Hamilton ecosystem to advance the commercialization of health innovation. Founded in 2016, this neutral advocate serves as a launchpad for health innovators and entrepreneurs, facilitating collaboration and strategic partnerships across the ecosystem. The consortium is a regional partnership comprising key public and private-sector stakeholders, including Canada's most research-intensive university, Ontario's most comprehensive hospital network, and over 25,000 life science staff and researchers, investing more than $500m in innovative research annually. Its last investment was a $300.00K Seed Round led by McMaster Seed Fund (MSF) in April 2022. Synapse operates within the biotechnology and health care sectors, with its headquarters located in Canada. Through its commitment to accelerating the commercialization of health innovation, Synapse offers a platform for engagement with the Hamilton health cluster, positioning itself as a crucial facilitator within the life sciences ecosystem.